Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/CURA stock hub

TSX/CURA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/CURAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.2B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/CURA

In the news

Latest news · TSX/CURA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-8.7

P25 -121.5P50 -40.9P75 0.5

ROIC0.9

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/CURA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	5,554
Employees Change	35%
Employees Change Percent	0.63
Enterprise value	CAD 5.6B
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA23126M1023
Last refreshed	2026-05-10
Market cap	CAD 4.2B
Price	CAD 5.32
Price currency	CAD
Rev Per Employee	323,139.33x
Sector	Healthcare
Sic	2834
Symbol	tsx/CURA
Website	https://www.curaleaf.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.29%
EV Earnings	-31.2x
EV/EBIT	240.09x
EV/EBITDA	14.85x
EV/FCF	72.29x
EV/Sales	3.14x
FCF yield	1.85%
P/B ratio	3.32x
P/S ratio	2.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.31%
EBITDA Margin	16.53%
FCF margin	4.35%
Gross margin	49.21%
Gross Profit	CAD 883.2M
Gross Profit Growth	-0.42%
Gross Profit Growth Q	1.11%
Gross Profit Growth3 Y	0.38%
Gross Profit Growth5 Y	6.43%
Net Income	CAD -180.8M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-7.03%
Profit Margin	-7.79%
Profit Per Employee	CAD -32,561
ROA	0.37
Roa5y	0.89
ROCE	0.67
ROE	-8.74
Roe5y	-18.31
ROIC	0.93
Roic5y	2.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	347.52%
Cagr3y	12.87%
Cagr5y	-21.81%
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth	-10.9%
FCF Growth Q	-82.09%
OCF Growth	-24.02%
OCF Growth Q	-45.39%
OCF Growth3 Y	140.22%
OCF Growth5 Y	71.92%
Revenue Growth	-1.25x
Revenue Growth Q	5.74x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.67x
Revenue Growth5 Y	10.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.45
Assets	CAD 3.9B
Cash	CAD 148.1M
Current Assets	CAD 630.9M
Current Liabilities	CAD 405.1M
Debt	CAD 1.5B
Debt EBITDA	CAD 3.83
Debt Equity	CAD 1.15
Debt FCF	CAD 18.62
Equity	CAD 1.3B
Interest Coverage	0.17
Liabilities	CAD 2.7B
Long Term Assets	CAD 3.3B
Long Term Liabilities	CAD 2.3B
Net Cash	CAD -1.3B
Net Cash By Market Cap	CAD -30.97
Net Debt EBITDA	CAD 4.4
Net Debt Equity	CAD 1.03
Net Debt FCF	CAD 16.72
Tangible Book Value	CAD -1.1B
Tangible Book Value Per Share	CAD -1.42
WACC	11.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.56
Inventory Turnover	2.8
Net Working Capital	CAD 198.5M
Quick ratio	0.6
Working Capital	CAD 230.6M
Working Capital Turnover	CAD 12.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	347.06%
200-day SMA	3.61
3Y total return	43.78%
50-day SMA	3.63
50-day SMA vs 200-day SMA	50over200
5Y total return	-70.77%
All Time High	23.3
All Time High Change	-77.17%
All Time High Date	2021-02-10
All Time Low	0.99
All Time Low Change	437.37%
All Time Low Date	2025-06-24
ATR	0.37
Beta	1.63
Beta1y	1.86
Beta2y	2.1
Ch YTD	56.01
High	5.46
High52	6.98
High52 Date	2025-12-18
High52ch	-23.73%
Low	5.21
Low52	0.99
Low52 Date	2025-06-24
Low52ch	437.37%
Ma50ch	46.44%
Price vs 200-day SMA	47.25%
RSI	66.4
RSI Monthly	57.68
RSI Weekly	69.08
Sharpe ratio	1.76x
Sortino ratio	3.22
Total Return	-3.6%
Tr YTD	56.01
Tr1m	69.97%
Tr1w	15.9%
Tr3m	62.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 23.5M
Operating Income Growth	-21.35
Operating Income Growth Q	-91.96
Operating Income Growth3 Y	-33.26
Operating Income Growth5 Y	-30.46
Operating margin	1.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	678,275,472%
Net Borrowing	-23,913,805.7
Shares Insiders	1.76%
Shares Institutions	3.45%
Shares Out	792,179,226
Shares Qo Q	2.57%
Shares Yo Y	3.6%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 21.1M
Average Volume	1,296,136.55x
Bv Per Share	1.47
CAPEX	CAD -89.8M
Ch1m	69.97
Ch1w	15.9
Ch1y	347.1
Ch3m	62.69
Ch3y	43.78
Ch5y	-70.77
Ch6m	43.01
Change	-0.75%
Change From Open	1.92
Close	5.36
Days Gap	-2.61
Depreciation Amortization	267,438,725.6
Dollar Volume	5,686,079.8
Earnings Date	2026-05-05
EBIT	CAD 23.5M
EBITDA	CAD 296.6M
EPS	CAD -0.23
F Score	7
FCF	CAD 78.1M
FCF EV Yield	1.38x
FCF Per Share	CAD 0.1
Financing CF	-92,789,794
Fiscal Year End	December
Founded	2,010
Goodwill	866,058,984.2
Income Tax	CAD -12.1M
Investing CF	-96,918,747
Is Primary Listing	1
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	3.67
Ma150ch	45.12%
Ma20	4.39
Ma20ch	21.24%
Net CF	-21,968,045
Open	5.22
P FCF Ratio	53.99
P OCF Ratio	25.1
Position In Range	44
Ppne	974,632,829.3
Price Date	2026-05-08
Price EBITDA	CAD 14.21
Relative Volume	0.83x
Revenue	1,794,715,828x
SBC By Revenue	3.17x
Share Based Comp	56,917,587
Tax By Revenue	-0.67x
Tr6m	43.01%
Volume	1,068,812
Z Score	0.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/CURA pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/CURA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/CURA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.4%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.6%

Negative means the company is buying back shares.

Technical

TSX/CURA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.4

Neutral momentum band

Price vs 200-day MA

+47.2%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

1.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/CURA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/CURA stock rating?

tsx/CURA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/CURA analysis?

The full report lives at /stocks/tsx/CURA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/CURA?

The latest report frames tsx/CURA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/CURA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.